Connection

James Ballenger to Panic Disorder

This is a "connection" page, showing publications James Ballenger has written about Panic Disorder.
Connection Strength

3.458
  1. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychol Med. 2003 Apr; 33(3):511-8.
    View in: PubMed
    Score: 0.198
  2. Comorbidity of panic and depression: implications for clinical management. Int Clin Psychopharmacol. 1998 Apr; 13 Suppl 4:S13-7.
    View in: PubMed
    Score: 0.140
  3. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry. 1998 Jan; 155(1):36-42.
    View in: PubMed
    Score: 0.138
  4. Treatment of panic disorder in the general medical setting. J Psychosom Res. 1998 Jan; 44(1):5-15.
    View in: PubMed
    Score: 0.138
  5. Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998; 59 Suppl 8:47-54.
    View in: PubMed
    Score: 0.138
  6. Sleep deprivation in panic disorder and obsessive-compulsive disorder. Can J Psychiatry. 1997 Nov; 42(9):982-3.
    View in: PubMed
    Score: 0.136
  7. Panic disorder in the medical setting. J Clin Psychiatry. 1997; 58 Suppl 2:13-7; discussion 18-9.
    View in: PubMed
    Score: 0.129
  8. Discussion and overview: what can we learn if we view panic disorder across the life span and across different presentations and contexts? Bull Menninger Clin. 1997; 61(2 Suppl A):A95-102.
    View in: PubMed
    Score: 0.129
  9. Predictors of quality of life in a long-term followup study in panic disorder patients after a clinical drug trial. Psychopharmacol Bull. 1996; 32(1):149-55.
    View in: PubMed
    Score: 0.120
  10. The DSM-IV panic disorder field trial: panic attack frequency and functional disability. Anxiety. 1996; 2(4):157-66.
    View in: PubMed
    Score: 0.120
  11. Panic disorder. Pathophysiology and drug treatment. Drugs. 1995 Mar; 49(3):328-44.
    View in: PubMed
    Score: 0.113
  12. Plasma and CSF HVA levels in panic patients with comorbid social phobia. Biol Psychiatry. 1994 Sep 15; 36(6):425-7.
    View in: PubMed
    Score: 0.110
  13. Overview of panic disorder. Trans Am Clin Climatol Assoc. 1994; 105:36-51; discussion 51-3.
    View in: PubMed
    Score: 0.104
  14. Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area project. Am J Psychiatry. 1994 Jan; 151(1):64-70.
    View in: PubMed
    Score: 0.104
  15. Medication discontinuation in panic disorder. J Clin Psychiatry. 1993 Oct; 54 Suppl:15-21; discussion 22-4.
    View in: PubMed
    Score: 0.103
  16. Comment on the London/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia. Br J Psychiatry. 1993 Jun; 162:788-9; discussion 790-4.
    View in: PubMed
    Score: 0.100
  17. Examining criteria for panic disorder. Hosp Community Psychiatry. 1993 Mar; 44(3):226-8.
    View in: PubMed
    Score: 0.099
  18. Panic disorder: efficacy of current treatments. Psychopharmacol Bull. 1993; 29(4):477-86.
    View in: PubMed
    Score: 0.098
  19. Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder. Psychopharmacol Bull. 1993; 29(2):183-8.
    View in: PubMed
    Score: 0.098
  20. The effects of pregnancy on preexisting panic disorder. J Clin Psychiatry. 1992 Jun; 53(6):201-3.
    View in: PubMed
    Score: 0.094
  21. Blood groups in panic disorder. Am J Psychiatry. 1992 Mar; 149(3):410.
    View in: PubMed
    Score: 0.092
  22. Medication discontinuation in panic disorder. J Clin Psychiatry. 1992 Mar; 53 Suppl:26-31.
    View in: PubMed
    Score: 0.092
  23. Cardiovascular status of panic disorder patients with and without prominent cardiac symptoms. Psychosomatics. 1992; 33(1):81-4.
    View in: PubMed
    Score: 0.091
  24. Irritable bowel syndrome in patients with panic disorder. Am J Psychiatry. 1991 Nov; 148(11):1614.
    View in: PubMed
    Score: 0.090
  25. Electroencephalography during sleep of patients with panic disorder. J Neuropsychiatry Clin Neurosci. 1989; 1(4):372-6.
    View in: PubMed
    Score: 0.074
  26. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
    View in: PubMed
    Score: 0.070
  27. Remission rates in patients with anxiety disorders treated with paroxetine. J Clin Psychiatry. 2004 Dec; 65(12):1696-707.
    View in: PubMed
    Score: 0.056
  28. Bupropion sustained release for panic disorder. Psychopharmacol Bull. 2003; 37(4):66-72.
    View in: PubMed
    Score: 0.049
  29. Treatment of anxiety disorders to remission. J Clin Psychiatry. 2001; 62 Suppl 12:5-9.
    View in: PubMed
    Score: 0.042
  30. Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. J Clin Psychiatry. 1999 May; 60(5):299-301.
    View in: PubMed
    Score: 0.038
  31. Panic disorder and quality of life: variables predictive of functional impairment. Am J Psychiatry. 1997 Jun; 154(6):766-72.
    View in: PubMed
    Score: 0.033
  32. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder. Am J Psychiatry. 1997 May; 154(5):700-2.
    View in: PubMed
    Score: 0.033
  33. Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry. 1995 Nov; 152(11):1665-7.
    View in: PubMed
    Score: 0.030
  34. Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry. 1995 Oct; 167(4):487-94.
    View in: PubMed
    Score: 0.029
  35. A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry. 1995 Apr 01; 37(7):462-6.
    View in: PubMed
    Score: 0.028
  36. Infrequent panic attacks: psychiatric comorbidity, personality characteristics and functional disability. J Psychiatr Res. 1995 Mar-Apr; 29(2):121-31.
    View in: PubMed
    Score: 0.028
  37. Predictors of response to alprazolam and placebo in patients with panic disorder. J Affect Disord. 1994 Jan; 30(1):5-13.
    View in: PubMed
    Score: 0.026
  38. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia. Am J Psychiatry. 1992 Nov; 149(11):1556-62.
    View in: PubMed
    Score: 0.024
  39. CSF diazepam-binding inhibitor concentrations in panic disorder. Biol Psychiatry. 1992 Oct 15; 32(8):712-6.
    View in: PubMed
    Score: 0.024
  40. Discontinuation of alprazolam after long-term treatment of panic-related disorders. J Clin Psychopharmacol. 1992 Oct; 12(5):352-4.
    View in: PubMed
    Score: 0.024
  41. CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects. Am J Psychiatry. 1992 May; 149(5):691-3.
    View in: PubMed
    Score: 0.023
  42. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder. J Clin Psychopharmacol. 1992 Apr; 12(2):96-103.
    View in: PubMed
    Score: 0.023
  43. CSF opioids in panic disorder. Biol Psychiatry. 1991 Sep 01; 30(5):512-4.
    View in: PubMed
    Score: 0.022
  44. Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects. Biol Psychiatry. 1996 Apr 15; 39(8):703-7.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.